Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Christopher Lieu

Concepts (385)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
47
2024
746
8.890
 Why?
Colonic Neoplasms
8
2024
242
2.700
 Why?
Antineoplastic Combined Chemotherapy Protocols
21
2024
1559
2.260
 Why?
Molecular Targeted Therapy
9
2019
385
2.030
 Why?
Antineoplastic Agents
14
2021
2051
1.990
 Why?
Biomarkers, Tumor
17
2025
1181
1.970
 Why?
Rectal Neoplasms
7
2023
136
1.770
 Why?
Antibodies, Monoclonal, Humanized
10
2024
755
1.750
 Why?
Bevacizumab
5
2024
129
1.700
 Why?
Benzimidazoles
3
2024
157
1.600
 Why?
Neoplasms
13
2024
2464
1.270
 Why?
Drug Resistance, Neoplasm
9
2024
749
1.230
 Why?
Mutation
14
2024
3689
1.100
 Why?
Age of Onset
9
2024
491
1.050
 Why?
Gastrointestinal Neoplasms
2
2025
72
1.010
 Why?
Immunotherapy
4
2022
587
0.940
 Why?
Neuroendocrine Tumors
6
2024
97
0.920
 Why?
Vascular Endothelial Growth Factor A
4
2020
500
0.900
 Why?
Neoplasm Staging
12
2024
1290
0.860
 Why?
Cetuximab
4
2023
93
0.840
 Why?
Oncologists
1
2023
35
0.840
 Why?
Microsatellite Instability
8
2024
37
0.830
 Why?
Proto-Oncogene Proteins p21(ras)
4
2019
258
0.830
 Why?
Proto-Oncogene Proteins B-raf
6
2024
214
0.800
 Why?
Pancreatic Neoplasms
8
2024
875
0.790
 Why?
Antibodies, Monoclonal
6
2023
1355
0.760
 Why?
Humans
94
2025
128417
0.710
 Why?
Pyrimidinones
2
2024
101
0.690
 Why?
Pyridones
2
2024
159
0.640
 Why?
Early Detection of Cancer
3
2024
369
0.620
 Why?
Piperidines
2
2017
190
0.600
 Why?
Colectomy
1
2019
93
0.600
 Why?
Circulating Tumor DNA
3
2025
28
0.600
 Why?
Cyclosporine
1
2018
169
0.580
 Why?
Middle Aged
38
2024
30889
0.560
 Why?
Terminology as Topic
1
2019
202
0.560
 Why?
Disease-Free Survival
7
2023
647
0.560
 Why?
Fluorouracil
6
2024
197
0.560
 Why?
Azetidines
1
2017
40
0.550
 Why?
Genetic Predisposition to Disease
4
2022
2264
0.550
 Why?
Appendiceal Neoplasms
2
2020
26
0.530
 Why?
Aged
29
2024
21953
0.500
 Why?
Medical Oncology
5
2023
271
0.500
 Why?
Adrenal Gland Neoplasms
3
2022
83
0.490
 Why?
Wnt Signaling Pathway
2
2024
165
0.490
 Why?
MAP Kinase Kinase Kinases
1
2015
71
0.480
 Why?
Patient Rights
1
2015
11
0.480
 Why?
Therapies, Investigational
1
2015
14
0.480
 Why?
Precision Medicine
1
2019
384
0.470
 Why?
Drug and Narcotic Control
1
2015
28
0.470
 Why?
Chemotherapy, Adjuvant
5
2024
376
0.470
 Why?
Adult
34
2024
35299
0.470
 Why?
Healthcare Disparities
1
2021
579
0.470
 Why?
Drugs, Investigational
1
2015
32
0.470
 Why?
Neovascularization, Pathologic
2
2013
290
0.460
 Why?
Adenocarcinoma
5
2023
888
0.440
 Why?
Pyrazines
2
2018
86
0.420
 Why?
Camptothecin
4
2024
106
0.420
 Why?
Clinical Trials as Topic
4
2025
993
0.420
 Why?
Drug Evaluation, Preclinical
1
2013
168
0.410
 Why?
Immunoglobulin G
1
2017
843
0.410
 Why?
Microsatellite Repeats
2
2024
161
0.410
 Why?
Male
39
2024
62857
0.410
 Why?
Drug Design
1
2013
154
0.400
 Why?
Leucovorin
5
2024
68
0.400
 Why?
ErbB Receptors
5
2017
601
0.390
 Why?
Neoadjuvant Therapy
5
2023
381
0.380
 Why?
Female
39
2024
68153
0.380
 Why?
Terminal Care
1
2015
234
0.370
 Why?
Neoplasm Metastasis
7
2022
608
0.370
 Why?
Carcinoma, Signet Ring Cell
1
2011
9
0.370
 Why?
Cell Transformation, Neoplastic
1
2013
325
0.360
 Why?
Treatment Outcome
13
2024
10151
0.350
 Why?
Carcinoma, Pancreatic Ductal
2
2024
265
0.350
 Why?
Imidazoles
2
2024
226
0.350
 Why?
Fibroblast Growth Factors
1
2011
170
0.340
 Why?
Clinical Decision-Making
4
2024
304
0.330
 Why?
Xenograft Model Antitumor Assays
6
2024
814
0.330
 Why?
src-Family Kinases
1
2010
95
0.320
 Why?
Patient Selection
3
2019
663
0.320
 Why?
Stomach Neoplasms
3
2022
97
0.310
 Why?
Disease Management
4
2021
587
0.300
 Why?
Boronic Acids
1
2008
37
0.300
 Why?
Janus Kinase 2
1
2008
32
0.290
 Why?
Etoposide
1
2008
149
0.290
 Why?
Carboplatin
1
2008
140
0.290
 Why?
Myeloproliferative Disorders
1
2008
26
0.290
 Why?
Health Services Accessibility
1
2015
896
0.290
 Why?
Genomics
3
2022
715
0.280
 Why?
Kaplan-Meier Estimate
6
2017
853
0.280
 Why?
Organoplatinum Compounds
2
2024
40
0.280
 Why?
Carcinoembryonic Antigen
2
2024
41
0.270
 Why?
Cancer Survivors
2
2024
263
0.270
 Why?
Pathology, Molecular
2
2017
25
0.270
 Why?
Shock, Septic
1
2009
205
0.270
 Why?
Pathology, Clinical
2
2017
36
0.270
 Why?
Drug Administration Schedule
4
2019
751
0.260
 Why?
ras Proteins
2
2017
145
0.250
 Why?
Age Factors
5
2021
3103
0.240
 Why?
Diagnosis, Differential
1
2009
1416
0.230
 Why?
Aged, 80 and over
11
2024
7033
0.230
 Why?
Oximes
1
2024
20
0.230
 Why?
United States
13
2025
13830
0.230
 Why?
CD3 Complex
1
2024
101
0.220
 Why?
Young Adult
5
2024
12312
0.210
 Why?
Antibodies, Bispecific
1
2024
49
0.210
 Why?
Metastasectomy
1
2023
19
0.210
 Why?
Signal Transduction
6
2018
4826
0.210
 Why?
Trifluridine
1
2022
3
0.210
 Why?
Clinical Trials, Phase II as Topic
2
2022
71
0.210
 Why?
Ovarian Neoplasms
2
2020
488
0.200
 Why?
Neoplasm Grading
2
2024
283
0.200
 Why?
Surgical Oncology
1
2022
22
0.200
 Why?
Clinical Trials, Phase III as Topic
2
2022
90
0.200
 Why?
Empathy
1
2024
170
0.200
 Why?
Disease Models, Animal
4
2021
3937
0.200
 Why?
Genetic Testing
3
2022
428
0.190
 Why?
Survival Rate
6
2023
1869
0.190
 Why?
Membrane Proteins
3
2019
1105
0.190
 Why?
Chemoradiotherapy, Adjuvant
2
2023
41
0.190
 Why?
Incidence
6
2022
2616
0.190
 Why?
Gene Regulatory Networks
1
2024
280
0.190
 Why?
Artificial Intelligence
1
2024
244
0.190
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2022
33
0.190
 Why?
Neoplasms, Multiple Primary
1
2022
54
0.190
 Why?
DNA
1
2008
1390
0.180
 Why?
Pheochromocytoma
1
2022
57
0.180
 Why?
Meningioma
1
2022
81
0.180
 Why?
Capecitabine
2
2022
46
0.180
 Why?
Health Status Disparities
2
2020
254
0.180
 Why?
Congresses as Topic
2
2019
212
0.180
 Why?
Heterografts
1
2021
129
0.170
 Why?
Practice Patterns, Physicians'
1
2009
1258
0.170
 Why?
Deoxycytidine
2
2024
163
0.170
 Why?
Immune System
1
2021
176
0.160
 Why?
Adenomatous Polyposis Coli Protein
1
2019
20
0.160
 Why?
Area Under Curve
2
2018
279
0.160
 Why?
Smad4 Protein
1
2019
37
0.160
 Why?
Cell Line, Tumor
4
2024
3184
0.160
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
81
0.160
 Why?
Consensus
2
2019
613
0.160
 Why?
GTP Phosphohydrolases
1
2019
84
0.160
 Why?
Retinal Vein
1
2019
13
0.160
 Why?
Dose-Response Relationship, Drug
2
2017
1936
0.160
 Why?
Prognosis
8
2023
3772
0.160
 Why?
Tumor Suppressor Protein p53
2
2022
508
0.160
 Why?
Cell-Free Nucleic Acids
1
2019
31
0.150
 Why?
Disease Progression
4
2017
2602
0.150
 Why?
B7-H1 Antigen
1
2020
189
0.150
 Why?
Vasculitis
1
2019
59
0.150
 Why?
Genes, ras
1
2018
98
0.150
 Why?
DNA Mismatch Repair
3
2024
47
0.150
 Why?
Proportional Hazards Models
3
2017
1196
0.150
 Why?
Cohort Studies
6
2020
5388
0.150
 Why?
Retinal Diseases
1
2019
86
0.150
 Why?
Drug Combinations
2
2022
323
0.150
 Why?
Risk Factors
6
2022
9704
0.150
 Why?
Survivorship
1
2018
48
0.140
 Why?
Neoplasm Transplantation
1
2018
258
0.140
 Why?
Population Surveillance
1
2021
427
0.140
 Why?
Liver Neoplasms
2
2024
633
0.140
 Why?
Risk Assessment
2
2019
3232
0.140
 Why?
Patient Advocacy
1
2018
74
0.140
 Why?
Evidence-Based Medicine
2
2019
711
0.140
 Why?
Acneiform Eruptions
1
2017
1
0.140
 Why?
Asthenia
1
2017
2
0.140
 Why?
Drug Eruptions
1
2017
25
0.140
 Why?
Neoplasm Recurrence, Local
2
2023
958
0.140
 Why?
Hypokalemia
1
2017
24
0.140
 Why?
Esophageal Neoplasms
1
2021
293
0.140
 Why?
Patient Compliance
1
2021
560
0.140
 Why?
Histone Deacetylase Inhibitors
1
2019
207
0.140
 Why?
Receptor, ErbB-3
1
2017
45
0.140
 Why?
MAP Kinase Kinase 1
1
2017
76
0.140
 Why?
Animals
10
2024
34479
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2019
228
0.130
 Why?
Intercellular Signaling Peptides and Proteins
2
2015
371
0.130
 Why?
Antineoplastic Agents, Immunological
1
2019
175
0.130
 Why?
Digestive System Neoplasms
1
2016
8
0.130
 Why?
Time Factors
2
2019
6482
0.130
 Why?
Hospitals
1
2021
631
0.130
 Why?
Biomarkers
3
2023
3880
0.130
 Why?
Triple Negative Breast Neoplasms
1
2019
191
0.130
 Why?
Insulin-Like Growth Factor I
1
2018
307
0.130
 Why?
Edema
1
2016
125
0.130
 Why?
Diabetic Neuropathies
1
2016
90
0.130
 Why?
Retrospective Studies
9
2023
14454
0.130
 Why?
Biliary Tract Neoplasms
1
2015
25
0.130
 Why?
Databases, Factual
3
2017
1269
0.130
 Why?
GPI-Linked Proteins
1
2016
67
0.120
 Why?
Analgesics
1
2016
163
0.120
 Why?
Delivery of Health Care, Integrated
1
2018
248
0.120
 Why?
Patient Care Planning
1
2016
149
0.120
 Why?
Device Approval
1
2015
21
0.120
 Why?
Neuralgia
1
2016
119
0.120
 Why?
Receptor, Notch1
1
2015
61
0.120
 Why?
Immunoblotting
1
2015
300
0.120
 Why?
Prevalence
1
2022
2547
0.120
 Why?
Quality of Life
2
2024
2680
0.120
 Why?
Pancreas
1
2017
304
0.120
 Why?
Health Behavior
1
2020
741
0.120
 Why?
Administration, Oral
1
2017
754
0.120
 Why?
Adolescent
4
2024
20179
0.120
 Why?
Gene Dosage
1
2015
142
0.120
 Why?
Immunoconjugates
1
2016
101
0.110
 Why?
Gene Expression Regulation
1
2024
2505
0.110
 Why?
Drug Approval
1
2015
86
0.110
 Why?
DNA Copy Number Variations
1
2015
169
0.110
 Why?
Genetic Variation
1
2019
933
0.110
 Why?
Quinazolines
1
2015
243
0.110
 Why?
Phenotype
2
2021
3044
0.110
 Why?
United States Food and Drug Administration
1
2015
199
0.110
 Why?
Delivery of Health Care
1
2021
895
0.110
 Why?
Lung Neoplasms
2
2024
2328
0.110
 Why?
Proto-Oncogene Proteins
1
2017
634
0.110
 Why?
beta Catenin
1
2015
219
0.110
 Why?
Spinal Cord Injuries
1
2016
193
0.110
 Why?
Oligonucleotide Array Sequence Analysis
1
2015
756
0.110
 Why?
Randomized Controlled Trials as Topic
1
2019
1356
0.100
 Why?
Registries
1
2021
1877
0.100
 Why?
Patient-Centered Care
1
2018
501
0.100
 Why?
National Cancer Institute (U.S.)
2
2025
43
0.100
 Why?
Lymphocytes
1
2015
367
0.100
 Why?
Protein Kinase Inhibitors
1
2018
872
0.100
 Why?
Angiogenesis Inhibitors
1
2013
215
0.100
 Why?
Risk
1
2014
853
0.100
 Why?
Ligands
1
2013
614
0.090
 Why?
Prospective Studies
3
2022
7036
0.090
 Why?
Patient Care Team
1
2016
605
0.090
 Why?
Mice
5
2024
16602
0.090
 Why?
Neoplasm, Residual
2
2022
119
0.090
 Why?
Protein-Tyrosine Kinases
1
2013
430
0.080
 Why?
Mice, Nude
2
2024
682
0.080
 Why?
Apoptosis
3
2022
2435
0.080
 Why?
Streptococcaceae
1
2009
2
0.080
 Why?
Transcriptome
1
2015
881
0.080
 Why?
Neutrophils
1
2015
1193
0.080
 Why?
Cytokines
2
2015
1983
0.080
 Why?
Patient Satisfaction
1
2013
641
0.080
 Why?
Clinical Medicine
1
2009
21
0.080
 Why?
Chemoradiotherapy
2
2023
209
0.080
 Why?
Myositis
1
2009
51
0.080
 Why?
Sulindac
1
2008
15
0.080
 Why?
Bortezomib
1
2008
45
0.080
 Why?
Mutation Rate
2
2019
25
0.070
 Why?
Taiwan
1
2008
19
0.070
 Why?
Combined Modality Therapy
1
2011
1204
0.070
 Why?
Maximum Tolerated Dose
1
2008
192
0.070
 Why?
Nausea
1
2008
107
0.070
 Why?
Neutropenia
1
2008
134
0.070
 Why?
Immunoenzyme Techniques
1
2008
206
0.070
 Why?
Multivariate Analysis
3
2017
1484
0.070
 Why?
Fluphenazine
1
2007
5
0.070
 Why?
Risperidone
1
2007
28
0.070
 Why?
Nerve Fibers, Myelinated
1
2007
43
0.070
 Why?
Drug Therapy, Combination
1
2010
1009
0.070
 Why?
Anemia
1
2008
160
0.070
 Why?
Food
1
2008
155
0.070
 Why?
Exons
1
2008
338
0.070
 Why?
Gastrectomy
2
2017
99
0.070
 Why?
Fasting
1
2008
264
0.070
 Why?
Thrombocytopenia
1
2008
181
0.070
 Why?
Frontal Lobe
1
2007
153
0.060
 Why?
Propensity Score
2
2017
264
0.060
 Why?
Postoperative Complications
1
2017
2485
0.060
 Why?
Antipsychotic Agents
1
2007
191
0.060
 Why?
Polymerase Chain Reaction
1
2008
1020
0.060
 Why?
Loneliness
1
2024
38
0.060
 Why?
Survival Analysis
2
2017
1263
0.060
 Why?
Delayed Diagnosis
1
2024
79
0.050
 Why?
Oxidative Stress
1
2010
1176
0.050
 Why?
Natural Language Processing
1
2024
94
0.050
 Why?
Organoids
1
2024
104
0.050
 Why?
Paclitaxel
1
2024
214
0.050
 Why?
Cyclooxygenase 2 Inhibitors
1
2022
21
0.050
 Why?
G2 Phase Cell Cycle Checkpoints
1
2022
45
0.050
 Why?
Resilience, Psychological
1
2024
123
0.050
 Why?
Endothelial Growth Factors
1
2022
51
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
64
0.050
 Why?
Gallium Radioisotopes
1
2022
14
0.050
 Why?
Radioisotopes
1
2022
31
0.050
 Why?
Receptors, Peptide
1
2022
17
0.050
 Why?
Radionuclide Imaging
1
2022
123
0.050
 Why?
Intestinal Neoplasms
1
2022
27
0.050
 Why?
Positron Emission Tomography Computed Tomography
1
2022
84
0.050
 Why?
Neoplastic Syndromes, Hereditary
1
2021
38
0.050
 Why?
Radiopharmaceuticals
1
2022
166
0.050
 Why?
Europe
1
2022
359
0.050
 Why?
North America
1
2022
289
0.050
 Why?
Surveys and Questionnaires
2
2024
5362
0.050
 Why?
Chimerism
1
2021
29
0.050
 Why?
Canada
1
2022
344
0.050
 Why?
Preventive Medicine
1
2021
41
0.040
 Why?
Lymphoid Tissue
1
2021
68
0.040
 Why?
Lymphocyte Subsets
1
2021
85
0.040
 Why?
Liquid Biopsy
1
2020
8
0.040
 Why?
Positron-Emission Tomography
1
2022
283
0.040
 Why?
Hyaluronic Acid
1
2022
211
0.040
 Why?
Mice, SCID
1
2021
350
0.040
 Why?
Geography
1
2020
186
0.040
 Why?
Morbidity
1
2021
301
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2022
221
0.040
 Why?
SEER Program
1
2020
206
0.040
 Why?
Mice, Inbred NOD
1
2021
586
0.040
 Why?
Spectrophotometry, Infrared
1
2019
53
0.040
 Why?
Sulfonamides
1
2022
499
0.040
 Why?
District of Columbia
1
2018
26
0.040
 Why?
Karnofsky Performance Status
1
2018
38
0.040
 Why?
Structure-Activity Relationship
1
2019
530
0.040
 Why?
Colon
1
2020
248
0.040
 Why?
Fluorescein Angiography
1
2019
143
0.040
 Why?
Multimodal Imaging
1
2019
109
0.040
 Why?
RNA
1
2024
880
0.040
 Why?
Half-Life
1
2017
143
0.040
 Why?
Melanoma
1
2024
752
0.030
 Why?
Tomography, Optical Coherence
1
2019
187
0.030
 Why?
American Medical Association
1
2017
16
0.030
 Why?
Genome, Human
1
2019
391
0.030
 Why?
Gene Expression Profiling
1
2024
1688
0.030
 Why?
Reproducibility of Results
1
2024
3020
0.030
 Why?
Delphi Technique
1
2018
221
0.030
 Why?
Lymphocytes, Tumor-Infiltrating
1
2019
210
0.030
 Why?
Genomic Instability
1
2017
47
0.030
 Why?
Needles
1
2016
56
0.030
 Why?
Cell Proliferation
1
2024
2344
0.030
 Why?
Radiotherapy, Adjuvant
1
2017
209
0.030
 Why?
Infusions, Intravenous
1
2017
385
0.030
 Why?
Health Services Needs and Demand
1
2018
264
0.030
 Why?
Radiotherapy, Intensity-Modulated
1
2017
128
0.030
 Why?
Algorithms
1
2024
1618
0.030
 Why?
Meta-Analysis as Topic
1
2017
169
0.030
 Why?
Retreatment
1
2016
69
0.030
 Why?
Molecular Diagnostic Techniques
1
2017
97
0.030
 Why?
Incidental Findings
1
2016
79
0.030
 Why?
Acute Disease
1
2019
964
0.030
 Why?
DNA Mutational Analysis
1
2017
384
0.030
 Why?
Platinum
1
2016
44
0.030
 Why?
Jagged-1 Protein
1
2015
22
0.030
 Why?
Serrate-Jagged Proteins
1
2015
27
0.030
 Why?
Gene Frequency
1
2017
504
0.030
 Why?
Neoplasm Invasiveness
1
2017
480
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
572
0.030
 Why?
Radiography
2
2016
859
0.030
 Why?
Gene Duplication
1
2015
67
0.030
 Why?
Magnetic Resonance Imaging
1
2007
3376
0.030
 Why?
Endoscopy, Digestive System
1
2016
122
0.030
 Why?
Preoperative Care
1
2017
338
0.030
 Why?
Tumor Microenvironment
1
2019
623
0.030
 Why?
Practice Guidelines as Topic
1
2022
1478
0.030
 Why?
Protein Isoforms
1
2016
378
0.030
 Why?
Mice, Knockout
1
2021
2755
0.030
 Why?
Leukocyte Count
1
2015
325
0.030
 Why?
Analysis of Variance
1
2017
1269
0.030
 Why?
Societies, Medical
1
2018
745
0.030
 Why?
Calcium-Binding Proteins
1
2015
210
0.030
 Why?
Ultraviolet Rays
1
2016
384
0.030
 Why?
Protein Processing, Post-Translational
1
2016
449
0.030
 Why?
Behavior, Animal
1
2016
484
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2019
846
0.030
 Why?
Brain Neoplasms
1
2021
1163
0.030
 Why?
Logistic Models
1
2017
1974
0.020
 Why?
Skin
1
2016
718
0.020
 Why?
Cross-Sectional Studies
1
2022
5039
0.020
 Why?
Follow-Up Studies
1
2020
4892
0.020
 Why?
Immunohistochemistry
1
2016
1664
0.020
 Why?
Rats, Sprague-Dawley
1
2016
2239
0.020
 Why?
Lung
1
2023
3743
0.020
 Why?
Protein Binding
1
2016
2103
0.020
 Why?
Angiogenesis Inducing Agents
1
2009
24
0.020
 Why?
Rats
1
2016
5165
0.020
 Why?
Glycogen Synthase Kinase 3 beta
1
2008
67
0.020
 Why?
Glycogen Synthase Kinase 3
1
2008
79
0.020
 Why?
Reference Standards
1
2008
168
0.020
 Why?
Pharmacogenetics
1
2008
171
0.020
 Why?
Breast Neoplasms
1
2019
2132
0.020
 Why?
Chromatography, High Pressure Liquid
1
2008
475
0.020
 Why?
Mice, Inbred C57BL
1
2016
5272
0.020
 Why?
Infusions, Intra-Arterial
1
1986
54
0.020
 Why?
Hepatic Artery
1
1986
58
0.020
 Why?
Tomography, X-Ray Computed
1
2016
2523
0.020
 Why?
Predictive Value of Tests
1
2011
1935
0.020
 Why?
Tandem Mass Spectrometry
1
2008
449
0.020
 Why?
Reference Values
1
2007
776
0.020
 Why?
Image Processing, Computer-Assisted
1
2007
735
0.010
 Why?
Longitudinal Studies
1
2007
2710
0.010
 Why?
Lieu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (385) concept(s)
_
Co-Authors Expand Description
See all (71) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)